Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Forodesine in Advanced, Fludarabine-Refractory CLL
NCT00289549Phase 2Completed
- Sponsor
- BioCryst Pharmaceuticals, Inc.
- Start
- Jun 2005
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of forodesine in chronic lymphocytic leukemia (CLL), sponsored by BioCryst Pharmaceuticals, Inc.. Started Jun 2005; status: completed.
02
Drugs
forodesine
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00289549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289549.